Topotecan inhibits VEGF- and bFGF-induced vascular endothelial cell migration via downregulation of the PI3K-Akt signaling pathway.
about
Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt inhibition in human glomerular endothelial cellsPDGF receptor-{beta} modulates metanephric mesenchyme chemotaxis induced by PDGF AAThe progress of angiogenic factors in the development of leukemiasElongation, proliferation & migration differentiate endothelial cell phenotypes and determine capillary sproutingPaeonol oxime inhibits bFGF-induced angiogenesis and reduces VEGF levels in fibrosarcoma cellsIL-17 contributes to angiogenesis in rheumatoid arthritis.Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.In vivo topoisomerase I inhibition attenuates the expression of hypoxia-inducible factor 1α target genes and decreases tumor angiogenesis.Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft modelGastrointestinal growth factors and hormones have divergent effects on Akt activation.Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience.Phyllanthus spp. Exerts Anti-Angiogenic and Anti-Metastatic Effects Through Inhibition on Matrix Metalloproteinase Enzymes.Genetic basis for developmental toxicity due to statin intake using embryonic stem cell differentiation model.Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway.Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.Myeloperoxidase oxidized LDL interferes with endothelial cell motility through miR-22 and heme oxygenase 1 induction: possible involvement in reendothelialization of vascular injuries.Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice.Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases.Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition.Antiangiogenic Effects of Ziyuglycoside II, a Major Active Compound of Sanguisorba officinalis L.Inhibitory effect of PDGF-BB and serum-stimulated responses in vascular smooth muscle cell proliferation by hinokitiol via up-regulation of p21 and p53.Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.
P2860
Q21262047-1740EB06-D44C-4264-A2CD-41BD52A1F910Q24300565-39E3E0F8-97DD-4A88-A31C-D349202985A7Q24316140-DE4D26E0-5963-41E4-9355-0B02AEBD2733Q26753835-E4053640-05F1-42F3-8DF6-08956350FBE2Q30487167-CEE86481-0F22-4C96-AAAA-6F2D32DFCDD3Q33680274-344AF555-9DD7-46C5-85CD-FAF64FD3D0FFQ33802908-ADC32570-9FA9-40B4-A429-341451A086D6Q34636137-49D12B61-2D72-4783-9052-D9A5727EAEA5Q35112115-B27240F7-0ADE-491E-AA3B-97E64086C967Q35718945-3F53BE41-124C-4C8D-BB36-81CB4FFE8FF3Q35800657-80B68254-A5B4-4C76-9A6B-A342D382CE79Q37180159-E7F41CD0-277E-4DA6-9EDC-7E2CEA8274C7Q37380284-8E75A3E5-CB1C-4A18-B397-D716DFC5185FQ38872674-A1B9412E-A4DB-4A84-8EAC-DFA8E49E77B8Q38906383-BBDF27C7-03CD-4C44-BDDE-7C673A0CBAD2Q40274284-1F5A617E-35A6-4BA6-82B8-275AF5B1CF1BQ40460534-455AD280-5B90-41A6-8C4D-C6529516469CQ41660975-2C09055A-7DBE-4DAC-A1CE-DE5F72A4855AQ41835547-0C3DBD69-3D71-432C-9639-64982384FE99Q42917027-FEC8B1AF-BF31-4B40-8D59-C798F7CFD9D2Q46930160-3176531B-1E5B-4676-BA39-0EB77ED5FB78Q47226338-B2B4F9EA-358D-43D5-8D6C-DED1C136CCDCQ48108969-FC01C6B7-1DB4-4A09-AACC-48C2F9CBE463Q54109570-09DF4B61-2A76-4831-838F-03FA40D1DFE7Q54634198-7BFF2D75-EC41-4662-B21E-3DAAD539F5FEQ55473120-14D6B8CD-ADB3-4B8A-82C7-5C4BAB0B6DA3
P2860
Topotecan inhibits VEGF- and bFGF-induced vascular endothelial cell migration via downregulation of the PI3K-Akt signaling pathway.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Topotecan inhibits VEGF- and b ...... he PI3K-Akt signaling pathway.
@en
Topotecan inhibits VEGF- and b ...... he PI3K-Akt signaling pathway.
@nl
type
label
Topotecan inhibits VEGF- and b ...... he PI3K-Akt signaling pathway.
@en
Topotecan inhibits VEGF- and b ...... he PI3K-Akt signaling pathway.
@nl
prefLabel
Topotecan inhibits VEGF- and b ...... he PI3K-Akt signaling pathway.
@en
Topotecan inhibits VEGF- and b ...... he PI3K-Akt signaling pathway.
@nl
P2093
P2860
P356
P1476
Topotecan inhibits VEGF- and b ...... he PI3K-Akt signaling pathway.
@en
P2093
Ayako Nakashio
Naoya Fujita
Takashi Tsuruo
P2860
P356
10.1002/IJC.10166
P577
2002-03-01T00:00:00Z